Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 2
1964 1
1966 2
1969 3
1972 1
1973 2
1974 3
1975 1
1976 4
1977 5
1978 3
1979 3
1980 6
1981 9
1982 6
1983 11
1984 18
1985 7
1986 12
1987 8
1988 11
1989 6
1990 8
1991 15
1992 16
1993 14
1994 16
1995 22
1996 24
1997 23
1998 30
1999 32
2000 24
2001 37
2002 38
2003 27
2004 31
2005 35
2006 25
2007 16
2008 19
2009 15
2010 18
2011 18
2012 29
2013 35
2014 31
2015 21
2016 23
2017 24
2018 31
2019 25
2020 37
2021 35
2022 43
2023 42
2024 27
2025 23
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

989 results

Results by year

Filters applied: . Clear all
Page 1
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.
Thomma RCM, Halstead SK, de Koning LC, Wiegers EJA, Gourlay DS, Tio-Gillen AP, van Rijs W, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Benedetti L, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Dardiotis E, Davidson A, Feasby TE, Fehmi J, Galassi G, Garcia-Sobrino T, Granit V, Gutiérrez-Gutiérrez G, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holt JKL, Islam Z, Karafiath S, Katzberg HD, Kolb N, Kusunoki S, Kuwabara S, Kuwahara M, Lehmann HC, Leonhard SE, Martín-Aguilar L, Monges S, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin RC, Rinaldi S, Ripellino P, Roberts RC, Scheidegger O, Shahrizaila N, Sheikh KA, Silvestri NJ, Sindrup SH, Stein B, Tan CY, Tankisi H, Visser LH, Waheed W, Huizinga R, Jacobs BC, Willison HJ; IGOS consortium. Thomma RCM, et al. Among authors: kuwahara m. Brain. 2025 Nov 4;148(11):4000-4015. doi: 10.1093/brain/awaf102. Brain. 2025. PMID: 40096525 Free PMC article.
Kuwahara et al. Reply.
Kuwahara M, Yoshida Y, Nagata W, Nakakura K, Furui M, Ishida T, Saitoh K, Ujihara T, Tanaka N. Kuwahara M, et al. Phys Rev Lett. 2021 Nov 24;127(22):229602. doi: 10.1103/PhysRevLett.127.229602. Phys Rev Lett. 2021. PMID: 34889629 No abstract available.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: kuwahara m. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
Takotsubo cardiomyopathy in Guillain-Barré syndrome.
Terayama A, Kuwahara M, Yoshikawa K, Yamagishi Y, Samukawa M, Yamashita S, Onishi K, Nagano T, Tatsumi C, Ishii J, Kawamoto M, Tokashiki T, Deguchi S, Deguchi K, Ishida A, Baba Y, Yamaguchi S, Kusunoki S, Nagai Y. Terayama A, et al. Among authors: kuwahara m. J Neurol. 2024 Jul;271(7):4067-4074. doi: 10.1007/s00415-024-12295-3. Epub 2024 Apr 4. J Neurol. 2024. PMID: 38573364
Adult-onset Asymmetrical Lipomatosis.
Aoki Y, Miyagawa F, Ogawa K, Yurugi S, Kuwahara M, Asada H. Aoki Y, et al. Among authors: kuwahara m. Acta Derm Venereol. 2020 Mar 12;100(6):adv00080. doi: 10.2340/00015555-3439. Acta Derm Venereol. 2020. PMID: 32115667 Free PMC article. No abstract available.
Imeglimin, a novel antidiabetic agent related to metformin, attenuates knee osteoarthritis development and progression through AMPK activation and NF-κB signaling inhibition.
Hyodo Y, Akasaki Y, Kurakazu I, Kuwahara M, Uchida T, Hirose R, Sakai M, Kita T, Kato K, Nakashima Y. Hyodo Y, et al. Among authors: kuwahara m. Osteoarthritis Cartilage. 2026 Jan;34(1):105-120. doi: 10.1016/j.joca.2025.11.007. Epub 2025 Nov 20. Osteoarthritis Cartilage. 2026. PMID: 41274455 Free article.
CANVAS-related RFC1 mutations in patients with immune-mediated neuropathy.
Hirano M, Kuwahara M, Yamagishi Y, Samukawa M, Fujii K, Yamashita S, Ando M, Oka N, Nagano M, Matsui T, Takeuchi T, Saigoh K, Kusunoki S, Takashima H, Nagai Y. Hirano M, et al. Among authors: kuwahara m. Sci Rep. 2023 Oct 18;13(1):17801. doi: 10.1038/s41598-023-45011-8. Sci Rep. 2023. PMID: 37853169 Free PMC article.
989 results